Tirzepatide is a dual GLP-1/GIP receptor agonist approved as Mounjaro and Zepbound, whereas Cagrilintide is an investigational amylin analog
The fundamental difference is that GLP-1 agonists eliminate hunger and create a state of pharmaceutical appetite suppression, while AOD-9604 leaves appetite entirely unchanged
Many patients find it helpful to get a Methyl B12 injection once a week
However, because BPC-157 and TB-500 promote angiogenesis (new blood vessel formation) and healing, theoretical concerns exist about providing blood supply to existing tumors
BPC-157 and TB-500 are the two most popular
It is naturally present in human plasma, saliva, and urine, and plays a proposed role in tissue maintenance and repair signalling